FDA Accepts for Priority Review Bristol Myers Squibb’s Application for Orencia (abatacept) for the Prevention of Acute Graft Versus Host Disease (aGvHD) Read more
Genevant Sciences Announces Global Collaboration and License Agreement with Takeda to Develop Novel Nonviral Gene Therapies for Up to Two Rare Liver Diseases Read more
Advanced RWE Applications in Pharma Summit is returning on October 26-28, 2021, for its 9th year Read more
Free exclusive webinar on ‘Multiscale and multi-modal insights into drug formulation’ – Join the experts! Read more
BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Nasopharyngeal Cancer Read more
FDA Approves Opdivo (nivolumab) for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma Read more